Altered profiles of serum amino acids in patients with sepsis and septic shock - Preliminary findings.


Journal

Archives of biochemistry and biophysics
ISSN: 1096-0384
Titre abrégé: Arch Biochem Biophys
Pays: United States
ID NLM: 0372430

Informations de publication

Date de publication:
30 09 2020
Historique:
received: 19 02 2020
revised: 28 05 2020
accepted: 14 07 2020
pubmed: 28 7 2020
medline: 25 11 2020
entrez: 27 7 2020
Statut: ppublish

Résumé

The clinical and diagnostic significance of systemic amino acids in sepsis and septic shock is unclear. Hence, the purpose of our study was to assess amino acids relationship with sepsis-related clinical data and to analyze whether they might have prognostic and discriminative value in sepsis and septic shock. Prospective and observational study with 5-day follow-up. Circulating amino acids were measured in 20 patients with sepsis or septic shock diagnosis and 30 healthy volunteers by means of targeted metabolomics (LC-MS/MS). Non-survivors were distinguished by significant elevated concentration of hPro (1st and 2nd day) and by mHis (5th day). Septic shock was associated with significant increased concentration of hPro (1st and 5th day) and Gly-Pro, His, Sarc and Phe (2nd day), Gly-Pro (3rd day) and Gly-Pro and mHis (5th day). In non-survivors was observed the rising trend in concentration of His (P = 0.04; 2nd day) and declining trend in concentration of Asn (P = 0.004; 5th day) and Pro (P = 0.03; 3rd day). In septic shock was observed mainly the declining trend in concentration of Arg (P = 0.03; 5th day), APA (P = 0.04; 2nd day), Lys (P = 0.02; 5th day), Sarc (P = 0.04; 5th day), Ser (P = 0.02; 5th day), Val (P = 0.04; 5th day), Trp (P = 0.03; 5th day) and Gly-Pro (P = 0.03; 2nd day; P = 0.02; 3rd day). Sepsis and septic shock are associated with altered concentration of serum amino acids indicative particularly of the intensified breakdown of muscle and connective tissue proteins leading to the accumulation of their characteristic degradation products. Some amino acids hold potential as predictors of sepsis progression and outcome but, in the light of discrepancies between studies, should be assessed in more numerous cohort study.

Sections du résumé

BACKGROUND
The clinical and diagnostic significance of systemic amino acids in sepsis and septic shock is unclear. Hence, the purpose of our study was to assess amino acids relationship with sepsis-related clinical data and to analyze whether they might have prognostic and discriminative value in sepsis and septic shock.
MATERIALS AND METHODS
Prospective and observational study with 5-day follow-up. Circulating amino acids were measured in 20 patients with sepsis or septic shock diagnosis and 30 healthy volunteers by means of targeted metabolomics (LC-MS/MS).
RESULTS
Non-survivors were distinguished by significant elevated concentration of hPro (1st and 2nd day) and by mHis (5th day). Septic shock was associated with significant increased concentration of hPro (1st and 5th day) and Gly-Pro, His, Sarc and Phe (2nd day), Gly-Pro (3rd day) and Gly-Pro and mHis (5th day). In non-survivors was observed the rising trend in concentration of His (P = 0.04; 2nd day) and declining trend in concentration of Asn (P = 0.004; 5th day) and Pro (P = 0.03; 3rd day). In septic shock was observed mainly the declining trend in concentration of Arg (P = 0.03; 5th day), APA (P = 0.04; 2nd day), Lys (P = 0.02; 5th day), Sarc (P = 0.04; 5th day), Ser (P = 0.02; 5th day), Val (P = 0.04; 5th day), Trp (P = 0.03; 5th day) and Gly-Pro (P = 0.03; 2nd day; P = 0.02; 3rd day).
CONCLUSION
Sepsis and septic shock are associated with altered concentration of serum amino acids indicative particularly of the intensified breakdown of muscle and connective tissue proteins leading to the accumulation of their characteristic degradation products. Some amino acids hold potential as predictors of sepsis progression and outcome but, in the light of discrepancies between studies, should be assessed in more numerous cohort study.

Identifiants

pubmed: 32712289
pii: S0003-9861(20)30517-8
doi: 10.1016/j.abb.2020.108508
pii:
doi:

Substances chimiques

Amino Acids 0
Biomarkers 0

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108508

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Magdalena Mierzchala-Pasierb (M)

Department of Medical Biochemistry of Wroclaw Medical University, Chalubinskiego 10, 50-368, Wroclaw, Poland. Electronic address: magdalena.mierzchala-pasierb@umed.wroc.pl.

Malgorzata Lipinska-Gediga (M)

Department of Anesthesiology and Intensive Therapy, Wroclaw Medical University, Borowska 213, 50-556, Wroclaw, Poland.

Mariusz G Fleszar (MG)

Department of Medical Biochemistry of Wroclaw Medical University, Chalubinskiego 10, 50-368, Wroclaw, Poland.

Patrycja Lesnik (P)

Department of Anesthesiology and Intensive Therapy, 4th Military Hospital of Wroclaw, Weigla 5, 50-981, Wroclaw, Poland; Department of Pathophysiology, Wroclaw Medical University, Marcinkowskiego 1, 50-368, Wroclaw, Poland.

Sylwia Placzkowska (S)

Diagnostics Laboratory for Teaching and Research, Wroclaw Medical University, Borowska 211A, 50-556, Wroclaw, Poland.

Pawel Serek (P)

Department of Medical Biochemistry of Wroclaw Medical University, Chalubinskiego 10, 50-368, Wroclaw, Poland.

Jerzy Wisniewski (J)

Department of Medical Biochemistry of Wroclaw Medical University, Chalubinskiego 10, 50-368, Wroclaw, Poland.

Andrzej Gamian (A)

Department of Medical Biochemistry of Wroclaw Medical University, Chalubinskiego 10, 50-368, Wroclaw, Poland.

Malgorzata Krzystek-Korpacka (M)

Department of Medical Biochemistry of Wroclaw Medical University, Chalubinskiego 10, 50-368, Wroclaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH